Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.48 USD | +1.64% | -0.80% | -0.80% |
Apr. 25 | OncoCyte Corporation announced that it has received $15.8 million in funding | CI |
Apr. 16 | Broadwood Capital, Inc. Engages with OncoCyte Corporation | CI |
Financials (USD)
Sales 2024 * | 1.45M | Sales 2025 * | 5.9M | Capitalization | 32.57M |
---|---|---|---|---|---|
Net income 2024 * | -22M | Net income 2025 * | -20M | EV / Sales 2024 * | 22.5 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 5.52 x |
P/E ratio 2024 * |
-1.02
x | P/E ratio 2025 * |
-1.23
x | Employees | 45 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.36% |
Latest transcript on OncoCyte Corporation
1 day | +1.64% | ||
1 week | -0.80% | ||
Current month | -15.36% | ||
1 month | -17.28% | ||
3 months | -20.77% | ||
6 months | +3.77% | ||
Current year | -0.80% |
Managers | Title | Age | Since |
---|---|---|---|
Joshua Riggs
CEO | Chief Executive Officer | 42 | 20-07-31 |
James Liu
DFI | Director of Finance/CFO | 29 | 21-06-30 |
Yuh-Min Chiang
CTO | Chief Tech/Sci/R&D Officer | - | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Last
BRD | Director/Board Member | 64 | 15-12-22 |
Alfred Kingsley
BRD | Director/Board Member | 81 | 09-08-31 |
Louis Silverman
BRD | Director/Board Member | 65 | 22-11-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 2.48 | +1.64% | 17,519 |
24-04-25 | 2.44 | -0.81% | 26,490 |
24-04-24 | 2.46 | +0.20% | 40,610 |
24-04-23 | 2.455 | -2.19% | 22,837 |
24-04-22 | 2.51 | +0.40% | 63,036 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.80% | 32.57M | |
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |
- Stock Market
- Equities
- OCX Stock